New hope for Hard-to-Treat kidney diseases in early trial
Disease control
Completed
This study tested an experimental drug called R3R01 for people with two serious kidney diseases: Alport Syndrome and Focal Segmental Glomerulosclerosis (FSGS). The main goal was to see if the drug was safe and if it could reduce high levels of protein in the urine, a key sign of …
Phase: PHASE2 • Sponsor: River 3 Renal Corp. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC